Blocking key enzyme to protect against fatty liver may raise cancer risk instead

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead ...
News Medical on MSN

Blocking liver enzyme Caspase-2 may increase long-term cancer risk

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic liver damage and cancer as we age.
ScienceAlert on MSN

Body Resurrects Cells Marked For Death, Solving a 50-Year Mystery

When tissue is severely damaged, surviving cells can respond in a concentrated burst of biological repair known as ...
Xinhuanet

Scientists warn of hidden cancer risk in popular fatty liver treatment strategy

Published in Science Advances, the study found that loss of the enzyme Caspase-2 drives abnormal growth in liver cells, triggering inflammation, fibrosis, and a significantly higher risk of liver ...

Ventus Therapeutics Announces Nomination of VENT-04, a First-in-Class, Oral, Small-Molecule Caspase-4/5 Inhibitor, as a Development Candidate

Ventus Therapeutics, a clinical-stage biopharmaceutical company advancing multiple small-molecule programs for autoimmune, ...